Use of hollow fiber membrane filtration for the removal of DMSO from platelet concentrates

It has been hypothesized that, in addition to freezing injury, some damage to platelets may result from the cell packing that occurs during removal of the cryoprotectant. This study examined DMSO removal by fluid exchange across hollow-fiber (HF) filters as an alternative to centrifugation. The DMSO solution with or without cell suspension was passed once through the filter. The optimum exchange during unloading of DMSO was determined by varying the flow rates in the external and internal compartments of the HF filter. Initially, buffered solutions of a 5% DMSO solution in the absence of platelets were pumped into the fibers and exchanged against PBS. The residual DMSO was determined by osmometry. The exchange of DMSO across the membrane was flow dependent and also influenced by the chemical nature of the HF fibers. No protocol using a reasonable rate flow through the fibers removed more than 95% of the DMSO in a single pass. The optimum protocol was achieved with polysynthane fibers with an internal flow rate of approximately 20 ml/min and an external flow rate of 100 ml/min. Subsequently, frozen/thawed platelet concentrates in DMSO were washed using centrifugation and compared to the HF filtration method. Platelet quality was assayed by flowcytometry, cell count, morphology and osmotic stress test. Both filtration and centrifugal washing techniques resulted in comparable morphological scores and numbers of discoid cells. When agents reducing platelet activation were added, platelet quality was improved after washing by either technique. The lower platelet osmotic response with HF filtration than with centrifugation while using activation inhibitors was attributed to the remaining amount of the inhibitors. All other parameters tested were similar. The expression of CD62P was equivalent with both techniques, and centrifugation did not activate platelets more than filtration contrary to what was originally anticipated. In conclusion, platelet quality was comparable after washing by either technique but hollow fiber filtration does remove cryoprotectant more rapidly than does centrifugation.

[1]  N. Mulder,et al.  Bleeding prophylaxis in autologous bone marrow transplantation for solid tumors. Comparison of cryopreserved autologous and fresh allogeneic single-donor platelets. , 1989, Haemostasis.

[2]  H. Borberg,et al.  First experience with a ready-for-use rheohemapheresis system. , 2001, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[3]  O. Tournilhac,et al.  Uncontrolled‐rate freezing and storage at –80°C, with only3.5‐percent DMSO in cryoprotective solution for 109 autologous peripheral blood progenitor cell transplantations , 2001, Transfusion.

[4]  N. Mourad A Simple Method for Obtaining Platelet Concentrates Free of Aggregates , 1968, Transfusion.

[5]  J. Harper,et al.  Cryopreservation of single‐donor platelets with a reduced dimethyl sulfoxide concentration by the addition of second‐messenger effectors: enhanced retention of in vitro functional activity , 1998, Transfusion.

[6]  J. Dutcher,et al.  PLATELET CRYOPRESERVATION USING DIMETHYL SULFOXIDE , 1983, Annals of the New York Academy of Sciences.

[7]  L. Weintraub,et al.  Cryopreservation of Human Platelets Using 6% Dimethyl Sulfoxide and Storage at ‐80° , 1985, Vox sanguinis.

[8]  Modelling of Plasma-Separation through Microporous Membranes , 1989, The International journal of artificial organs.

[9]  N. K. Wills,et al.  Osmotic Regulation of Na+ Transport Across A6 Epithelium: Interactions with Prostaglandin E2 and Cyclic AMP , 1997, The Journal of Membrane Biology.

[10]  T. Ino,et al.  Platelet damage caused by the centrifugal pump: laser-light scattering analysis of aggregation patterns. , 2001, Artificial organs.

[11]  Wolfgang Muntean,et al.  Flow cytometric detection of intracellular platelet antigens. , 1996, Cytometry.

[12]  J. White,et al.  Effects of the addition of second‐messenger effectors to platelet concentrates separated from whole‐blood donations and stored at 4°C or –80°C , 2000 .

[13]  H. Kiyokawa,et al.  Prevention of acquired defects in platelet function during blood processing , 1988, Transfusion.

[14]  C. Lechuga,et al.  Dipyridamole stimulates types II cAMP-dependent protein kinase in vitro , 1992, Molecular and Cellular Biochemistry.

[15]  Semple,et al.  Preanalytical requirements for flow cytometric evaluation of platelet activation: choice of anticoagulant , 1999, Transfusion medicine.

[16]  R. Aster,et al.  A Study of Variables Affecting the Quality of Platelets Stored at “Room Temperature” , 2003, Transfusion.

[17]  J. Corral,et al.  A radioreceptor assay for mass measurement of inositol (1,4,5)-trisphosphate using saponin-permeabilized outdated human platelets. , 1998, Analytical biochemistry.

[18]  J. Vienken,et al.  Considerations on developmental aspects of biocompatible dialysis membranes. , 1995, Artificial organs.

[19]  J. White,et al.  Effects of the addition of second-messenger effectors to platelet concentrates separated from whole-blood donations and stored at 4 degrees C or -80 degrees C. , 2000, Transfusion.

[20]  W. Clark,et al.  Clinical evaluation of a new high efficiency hemodialyzer: polysynthane. , 1999 .

[21]  U. Kralisz,et al.  Comparison of platelet aggregability and P-selectin surface expression on platelets isolated by different methods. , 2000, Thrombosis research.

[22]  M. Chen,et al.  In situ phosphorylation of platelet actin-binding protein by cAMP-dependent protein kinase stabilizes it against proteolysis by calpain. , 1989, The Journal of biological chemistry.

[23]  Y. Misawa,et al.  Evaluation of platelet damage in two different centrifugal pumps based on measurements of alpha-granule packing proteins. , 1998, Artificial organs.

[24]  F. Arnaud Frozen/thawed platelets: importance of osmotic tolerance and platelet subpopulations. , 1999, Cryobiology.

[25]  W. Clark,et al.  Clinical evaluation of a new high efficiency hemodialyzer: polysynthane. , 1999, ASAIO journal.